THBS4 Antibody

What are the optimal applications for detecting THBS4 in tissue samples?

THBS4 can be effectively detected using multiple techniques, with Western blot, immunohistochemistry (IHC), and immunofluorescence being the most reliable methods. For Western blot detection, reducing conditions are recommended with distinct bands appearing at approximately 120-130 kDa in human heart tissue samples . For immunohistochemistry applications, antigen retrieval and specific blocking protocols significantly enhance detection sensitivity. Paraffin-embedded sections typically require citrate buffer-based antigen retrieval at pH 6.0, while frozen sections may be fixed with 4% paraformaldehyde prior to antibody incubation .

Validation studies have demonstrated that anti-THBS4 antibodies perform optimally when:

• Using 0.2-2 μg/mL concentration for Western blot detection

• Applying 5 μg/mL concentration for immunohistochemistry

• Employing 1:100-1:300 dilutions for immunofluorescence applications

For skeletal muscle tissues specifically, connective tissue elements show pronounced THBS4 immunostaining, providing important localization information .

How should researchers validate the specificity of THBS4 antibodies?

Proper validation requires multiple complementary approaches:

• Positive control selection: Human heart tissue, skeletal muscle, and specific cancer tissues (particularly gastric carcinoma) show reliable THBS4 expression . Mouse muscle tissue also provides a consistent positive control .

• Knockout/knockdown validation: Compare staining patterns between wild-type and Thbs4−/− tissues. Complete absence of signal in knockout tissues confirms antibody specificity .

• Western blot profile analysis: Multiple bands may be observed (75-140 kDa range) due to post-translational modifications and glycosylation patterns of THBS4. The primary band should appear consistently at approximately 120-130 kDa in reducing conditions .

• Cross-reactivity assessment: Test against recombinant THBS4 from different species. Many antibodies show partial cross-reactivity between human and mouse THBS4 (approximately 10-50% cross-reactivity is common) .

• Immunoprecipitation confirmation: Verify antibody specificity by immunoprecipitation followed by Western blot analysis using tissue lysates with known THBS4 expression .

How can THBS4 antibodies be utilized to investigate the cellular source of THBS4 in disease states?

THBS4 expression patterns vary significantly in pathological conditions, requiring careful experimental design to identify cellular sources. For comprehensive analysis:

• Co-localization studies: Perform dual immunofluorescence staining using THBS4 antibodies in combination with cell-type specific markers:

  • αSMA or Podoplanin for cancer-associated fibroblasts (CAFs)

  • CD68 for macrophages

  • Pan-cytokeratin for epithelial/cancer cells

  • Endothelial markers such as CD31

Research has demonstrated that in gastric cancer microenvironments, THBS4 colocalizes with αSMA-positive or Podoplanin-positive stromal cells but not with cytokeratin-positive cancer cells, suggesting CAFs as the primary source .

• Comparative expression analysis: Compare THBS4 expression between:

  • Cancer-associated fibroblasts (CAFs) vs. normal-associated fibroblasts (NFs)

  • Primary tumor cells vs. metastatic lesions

  • Inflammatory vs. non-inflammatory conditions

• Cell-type specific isolation: Isolate specific cell populations using cell sorting techniques followed by Western blot analysis to quantitatively determine which cells produce THBS4 .

In LPS-induced peritonitis models, macrophages have been identified as significant sources of THBS4, with expression increasing in response to inflammatory stimuli . In cancer models, CAFs consistently demonstrate higher THBS4 expression than normal fibroblasts or cancer cells .

What methodological approaches should be used to study THBS4 in inflammatory responses?

THBS4 plays significant roles in vascular inflammation, requiring specialized methodological approaches:

• Temporal expression analysis: Monitor THBS4 expression at multiple time points following inflammatory stimulation:

  • Early response (1-6 hours)

  • Intermediate response (12-24 hours)

  • Late response (24-72 hours)

• Cell culture systems:

  • In RAW264.7 macrophage cells, LPS treatment (0.5 μg/ml) induces significant THBS4 expression after 24 hours of stimulation

  • Cyclohexamide (CHX) chase experiments (25 μM) can help determine THBS4 protein stability

• In vivo inflammatory models:

  • LPS-induced peritonitis model: Compare peritoneal macrophage THBS4 expression between control and treated mice

  • Vascular inflammation models: Analyze Thbs4^-/-^ mice crossed with ApoE^-/-^ mice to assess atherosclerotic lesion development and inflammatory cell infiltration

• Quantification approaches:

  • qRT-PCR for transcriptional changes

  • Western blot for protein level alterations

  • Immunofluorescence for spatial distribution changes

  • ELISA for secreted THBS4 quantification

Research has shown that in peritoneal tissue from mice with LPS-induced peritonitis, THBS4 expression increases significantly in macrophages, and this can be reliably detected using appropriately validated antibodies .

How can researchers investigate the relationship between THBS4 and signaling pathways in cancer progression?

Understanding THBS4's role in cancer signaling requires sophisticated experimental designs:

• Pathway interaction studies:

  • TGFβ pathway: TGFβ treatment (1-20 μM, 20 hours) can induce THBS4 protein expression and secretion without affecting mRNA levels

  • PDGF signaling: PDGF-D stimulation (8 hours) increases cellular THBS4 protein levels and secretion

  • Ca²⁺ signaling: Inhibit IP3R with 2-APB or STIM1 with ML-9 (5-100 μM, 16 hours) to assess effects on THBS4 secretion

• Inhibitor analysis:

  • PDGFRβ inhibition using imatinib (0.2-5 μM, 16 hours) reduces THBS4 expression in a dose-dependent manner

  • Compare pathway inhibition effects on both intracellular and secreted THBS4 levels

• Sequential signaling studies:

  • Treatment timeline experiments to establish causality:

    • TGFβ treatment shows peak PDGF-D expression at 12 hours

    • PDGF-D levels peak at 12 hours after TGFβ treatment

    • THBS4 levels typically increase from 12-20 hours after TGFβ treatment

Research data indicates that in colorectal cancer models, TGFβ increases PDGF-D expression, which subsequently increases THBS4 through PDGFRβ in a sequential manner, with Ca²⁺ signaling proteins playing critical roles in this process .

How should THBS4 expression be evaluated in cancer tissue microarrays for prognostic studies?

For standardized evaluation in clinical specimens:

What techniques should be used to investigate THBS4's role in muscular dystrophy research?

THBS4 is significantly induced in muscular dystrophy, necessitating specialized approaches:

• Mouse model selection and analysis:

  • mdx mice (modeling Duchenne muscular dystrophy)

  • Sgcd^-/-^ mice (modeling limb-girdle muscular dystrophy 2F)

  • Transgenic mice overexpressing THBS4 in skeletal muscle

• Functional assessments:

  • Evaluate serum creatine kinase levels as a marker of muscle damage

  • Quantify centrally nucleated myofibers to assess degeneration/regeneration cycles

  • Measure fibrotic remodeling through histological analysis

  • Perform functional strength tests at different time points (3 and 12 months)

• Membrane integrity evaluation:

  • Evans blue dye (EBD) uptake assay following forced treadmill running to assess sarcolemmal integrity

  • Quantification of EBD-positive fibers as a percentage of total myofibers

• ER stress analysis:

  • Monitor cleaved ATF6α-N (nuclear form)

  • Quantify BiP levels as indicators of ER stress response

  • Compare expression patterns between wild-type and muscular dystrophy models

Research has demonstrated that THBS4 overexpression can significantly reduce multiple histopathological hallmarks of dystrophic disease, including elevated serum CK levels, centrally nucleated myofibers, fibrotic remodeling, and functional decline in both Sgcd^-/-^ and mdx mice .

How can researchers optimize Western blot detection of THBS4 when experiencing detection challenges?

When encountering difficulties with THBS4 detection by Western blot:

• Sample preparation optimization:

  • Use RIPA buffer supplemented with protease inhibitors for tissue lysis

  • For muscle tissues, include mechanical homogenization steps

  • Increase protein concentration to 20-50 μg per lane for difficult samples

• Electrophoretic considerations:

  • Use 8-10% SDS-PAGE gels to better resolve the 120-130 kDa THBS4 protein

  • Extend running time to improve separation of high molecular weight proteins

  • Apply reducing conditions using 2-mercaptoethanol or DTT

  • Use Immunoblot Buffer Group 1 for optimal results

• Antibody optimization:

  • Test a range of primary antibody concentrations (0.2-2 μg/mL)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use 5% non-fat dry milk in TBST as the optimal blocking buffer

• Detection system selection:

  • For mouse skeletal muscle, HRP-conjugated anti-sheep IgG secondary antibody works effectively with sheep polyclonal anti-THBS4 antibodies

  • For human samples, anti-rabbit secondary antibodies work well with rabbit monoclonal anti-THBS4 antibodies

• Alternative detection methods:

  • Consider using the Simple Western™ automated Western blot system for improved sensitivity, which has shown effective detection of THBS4 at approximately 158 kDa in human heart tissue

What approaches should researchers employ to resolve inconsistent THBS4 staining patterns in immunohistochemistry?

When facing variable or inconsistent THBS4 immunostaining:

• Tissue processing standardization:

  • For paraffin sections: Use consistent fixation times (24 hours in 10% neutral buffered formalin)

  • For frozen sections: Fix with 4% paraformaldehyde prior to antibody incubation

  • Perform antigen retrieval using citrate buffer (pH 6.0) with consistent heating parameters

• Antibody validation across multiple samples:

  • Include known positive controls (heart, skeletal muscle) in each staining batch

  • Use both normal and pathological tissues to establish expression patterns

  • Compare staining patterns with published literature reports

• Signal amplification techniques:

  • For weakly expressing tissues, apply a polymer-based detection system

  • Use tyramide signal amplification for detecting low abundance expression

  • Consider using anti-sheep HRP-DAB Cell & Tissue Staining Kit for optimal results with sheep polyclonal antibodies

• Background reduction strategies:

  • Use endogenous peroxidase blocking (3% H₂O₂ in methanol, 10 minutes)

  • Apply protein blocking with 5% normal serum from secondary antibody species

  • Include avidin-biotin blocking steps if using biotin-based detection systems

• Methodological verification:

  • Compare immunohistochemistry results with Western blot findings from the same tissues

  • Perform dual immunofluorescence with cell type-specific markers to confirm expression patterns

How should researchers interpret THBS4 expression patterns when comparing different disease models?

Proper interpretation requires systematic comparative analysis:

• Standardized quantification methods:

  • Apply consistent scoring systems across different disease models

  • Use digital image analysis software for objective quantification

  • Report both intensity and distribution parameters

• Cell type-specific expression analysis:

  • In gastric cancer: THBS4 is predominantly expressed by cancer-associated fibroblasts (CAFs)

  • In inflammatory conditions: Macrophages significantly upregulate THBS4 expression

  • In muscular dystrophy: Skeletal muscle fibers show increased THBS4 expression

• Comparative expression profiles:

  Disease Model	Primary THBS4 Source	Expression Pattern	Functional Implication
  Gastric cancer	Cancer-associated fibroblasts	Stromal expression, particularly in diffuse-type	Poor prognosis marker
  Peritonitis	Macrophages	Induced by LPS stimulation	Promotes macrophage accumulation
  Muscular dystrophy	Skeletal muscle fibers	Induced in response to muscle damage	Adaptive ER stress response
  Atherosclerosis	Vascular wall components	Expressed in atherosclerotic lesions	Regulates inflammation
  Colorectal cancer	Stromal cells	Induced by TGFβ-PDGF-D-PDGFRβ signaling	Promotes tumor development

• Context-dependent function interpretation:

  • In muscle: THBS4 appears protective through ER stress regulation

  • In cancer: THBS4 typically correlates with worse outcomes

  • In vascular disease: THBS4 promotes inflammation

• Temporal expression considerations:

  • Acute vs. chronic expression patterns

  • Early vs. late disease stage expression

What are the key considerations when analyzing contradictory THBS4 functional data across different experimental systems?

Researchers face conflicting reports about THBS4 functions; these discrepancies should be analyzed by:

• Experimental system characterization:

  • In vitro vs. in vivo models

  • Cell lines vs. primary cells

  • Genetic knockout vs. overexpression models

  • Acute vs. chronic manipulations

• Reconciliation strategies:

  • Context-dependent functions: THBS4 may function differently in different tissues

  • Dose-dependent effects: Low vs. high expression levels may activate different pathways

  • Temporal considerations: Early protective effects may differ from chronic effects

• Contradictory findings examples:

  Research Area	Supporting Evidence	Contradictory Evidence	Potential Reconciliation
  Cancer progression	THBS4 promotes metastasis in gastric cancer	Some studies report tumor suppressor functions	Cell type-specific effects; THBS4 from CAFs vs. cancer cells may have different functions
  Inflammation	THBS4 promotes macrophage accumulation	May have anti-inflammatory roles in some contexts	Tissue-specific microenvironmental factors modify THBS4 function
  Tissue remodeling	THBS4 can promote fibrosis	THBS4 contributes to wound healing	Balance between beneficial remodeling and pathological fibrosis depends on context

• Methodological differences analysis:

  • Antibody clones and epitopes recognized

  • Detection techniques employed

  • Model systems utilized

  • Endpoints measured

• Signaling pathway interactions:

  • THBS4 interacts with multiple signaling pathways (TGFβ, PDGF, Ca²⁺ signaling)

  • Pathway predominance varies by cell type and disease context

By systematically analyzing these factors, researchers can better understand the context-dependent functions of THBS4 and reconcile apparently contradictory results.

What methodological advances would enhance THBS4 detection in extracellular vesicles and secretomes?

Emerging research indicates THBS4 may be secreted via extracellular vesicles, requiring specialized detection approaches:

• Extracellular vesicle isolation optimization:

  • Differential ultracentrifugation protocols tailored for THBS4-containing vesicles

  • Size exclusion chromatography to separate THBS4-containing vesicle subpopulations

  • Immunoaffinity capture using THBS4 antibodies for specific isolation

• Proteomic analysis enhancements:

  • Targeted mass spectrometry for THBS4 peptide detection

  • Stable isotope labeling approaches to quantify relative THBS4 abundance

  • Post-translational modification mapping to identify secreted THBS4 variants

• Live-cell imaging techniques:

  • THBS4-GFP fusion protein expression to track secretion dynamics

  • Super-resolution microscopy to visualize THBS4 incorporation into vesicles

  • Total internal reflection fluorescence (TIRF) microscopy to monitor secretion events

• Secretome analysis approaches:

  • Serum-free conditioned media collection with optimized timing (8-24 hours post-stimulation)

  • Concentration techniques that preserve THBS4 structure and immunoreactivity

  • Comparison between cellular and secreted THBS4 forms

• Validation standards:

  • Recombinant THBS4 standards for absolute quantification

  • Consistent reporting formats for THBS4 detection in extracellular vesicles

How can single-cell techniques be applied to investigate THBS4 expression heterogeneity in complex tissues?

Advanced single-cell approaches offer new opportunities to understand THBS4 biology:

• Single-cell RNA sequencing applications:

  • Identify cell populations with heterogeneous THBS4 expression

  • Correlate THBS4 expression with specific cell states or activation profiles

  • Map THBS4-expressing cells within tissue microenvironments

• Spatial transcriptomics integration:

  • Combine THBS4 antibody staining with spatial transcriptomics platforms

  • Map THBS4 protein expression relative to mRNA distribution

  • Identify spatial relationships between THBS4-expressing and THBS4-responsive cells

• Mass cytometry approaches:

  • Develop metal-conjugated THBS4 antibodies for CyTOF analysis

  • Create comprehensive panels including THBS4 and relevant signaling markers

  • Quantify THBS4 expression across multiple cell types simultaneously

• In situ protein analysis:

  • Multiplex immunofluorescence combining THBS4 with cell type markers

  • Proximity ligation assays to identify THBS4 interaction partners in situ

  • Single-cell Western blot techniques for protein isoform analysis

• Lineage tracing of THBS4-expressing cells:

  • THBS4 promoter-driven reporter mouse models

  • Inducible genetic labeling of THBS4-expressing cell populations

  • Fate mapping of THBS4-positive cells during disease progression

These advanced methodologies promise to reveal previously unrecognized heterogeneity in THBS4 expression patterns and functions across diverse pathophysiological contexts.